Procalcitonin as a Predictive Marker of Incident Liver Disease

ABSTRACT Background and Aims Previous studies have shown that procalcitonin (PCT) concentration is elevated in patients with liver disease without evidence of bacterial infection. We aimed to investigate the association between elevated PCT and the future risk of liver disease. Method PCT was measur...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Liver international Ročník 45; číslo 6; s. e70132 - n/a
Hlavní autoři:	Finnberg‐Kim, Amanda, Pihlsgård, Mats, Önnerhag, Kristina, Melander, Olle, Enhörning, Sofia
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Wiley Subscription Services, Inc 01.06.2025 John Wiley and Sons Inc
Témata:	Aged Bacterial diseases Biomarkers - blood C-reactive protein Clinical Medicine Confidence intervals Female Gastroenterologi och hepatologi Gastroenterology and Hepatology Humans Incidence Klinisk medicin Liver liver cirrhosis liver disease Liver diseases Liver Diseases - blood Liver Diseases - diagnosis Liver Diseases - epidemiology Male Medical and Health Sciences Medicin och hälsovetenskap Middle Aged Multivariate Analysis Original Predictive Value of Tests Procalcitonin Procalcitonin - blood Proportional Hazards Models Regression analysis Regression models Risk assessment Risk Factors Sensitivity analysis Statistical analysis Sweden - epidemiology Sweden risk assessment procalcitonin liver disease C‐reactive protein liver cirrhosis
ISSN:	1478-3223, 1478-3231, 1478-3231
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!